NCT02678533View on ClinicalTrials.gov

Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 10, 2017

Primary Completion Date

November 20, 2018

Study Completion Date

May 3, 2019

Conditions
Fanconi Anemia
Interventions
DRUG

G-CSF

D1 to D4 : Injection of 12 µg/kg of G-CSF twice a day . D5 : injection of 12 µg/kg of G-CSF (once/ twice a day according to cytapheresis's realization)

DRUG

Plerixafor

D5 : injection of 24mg/kg of plerixafor once a day until cytapheresis has be done (maximum of 4 days)

Trial Locations (1)

75015

Hôpital necker-Enfants malades, Paris

All Listed Sponsors
collaborator

EuroFancolen

UNKNOWN

collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02678533 - Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor | Biotech Hunter | Biotech Hunter